7 Biggest Price Target Changes For Tuesday By: Benzinga via Benzinga November 29, 2016 at 09:39 AM EST Barclays cut BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) price target from $125 to $105. BioMarin Pharmaceutical ... Read More >> Related Stocks: Amicus Therapeutics Biomarin Pharmaceuticals Johnson & Johnson Palo Alto Networks Inc United Therapeutic